Human IFN-γ ELISA antibody pair - 10-plate

SKU
CT740-10
Validated ELISA antibody pair with standard and conjugate; reagents available separately (960 determinations).
Format
10-plate
Price
€ 625
Documentation
Data sheet
Manual
SDS
Reactivity
Human
Category
ELISA
Analyte
IFN-γ
Description
Our ELISA antibody pairs are extensively validated for high assay performance using the same reagents and materials included in U-CyTech ELISA kits. These antibody pairs are optimized to ensure reliable, sensitive, and reproducible results in a wide range of ELISA applications.
The ELISA antibody pairs are available in convenient 10- or 20-plate formats, providing 960 or 1920 determinations, respectively. Each set is supplied with either 5 or 10 vials of standards and 2 or 4 vials of Streptavidin-HRP conjugate, offering flexibility for different experimental needs and throughput requirements.
Designed for ease of use and consistent performance, these ELISA reagents support accurate quantification in immunoassays. Additional ELISA plates and reagents can be purchased separately, allowing customization of your ELISA workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
3458

References

Authors, et al. Title Journal Year Volume Pages
Jemal Hussein A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area Trials 2018 19 24
Anita van der Zwan Cross-Reactivity of Virus-Specific CD8+ T Cells Against Allogeneic HLA-C: Possible Implications for Pregnancy Outcome Front Immunol 2018 9 2880
H van den Heuvel Allo-HLA Cross-Reactivities of Cytomegalovirus-, Influenza-, and Varicella Zoster Virus-Specific Memory T Cells Are Shared by Different Healthy Individuals Am J Transplant 2017 17 2033-2044
Mohsen Masjedi Cytokine Indexes in Pemphigus Vulgaris: Perception of Its Immunpathogenesis and Hopes for Non-Steroidal Treatment Iran J Pharm Res 2017 16 1223-1229
Yongkang Wu Adipose Tissue-Derived Mesenchymal Stem Cells Have a Heterogenic Cytokine Secretion Profile Stem Cells Int 2017 2017 4960831
Mardi Boer KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults Tuberculosis (Edinb) 2016 97 163-71
Heleen van den Heuvel Detection of Virus-Specific CD8+ T Cells With Cross-Reactivity Against Alloantigens: Potency and Flaws of Present Experimental Methods Transplant Direct 2015 1 e40
Saraswoti Khadge Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal BMC Infect Dis 2015 15 477
Mardi Boer Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults Clin Vaccine Immunol 2015 22 778-88
G Bakdash Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells Mucosal Immunol 2015 8 265-78